The Foundation congratulates Toronto-based Profound Medical, Inc., winner of the prestigious, 2010 Ontario Premier’s Catalyst Award for “Start-up Company with the Best Innovation.” The Ontario government will also invest C$ 200,000 in further developing the company’s investigational MR-guided focused ultrasound device for treating prostate cancer.
The company is in the midst of securing financing to accelerate clinical trials in North America, Canada and the European Union.
Paul Chipperton, CEO of Profound Medical, noted, “We have met the FDA, we have our sites selected, and we are working with literally the most experienced and best clinicians in the world. Once additional financing has been secured, the company is prepared to immediately hire 6-10 new employees to make this happen. We can’t wait to embark on our next phase of growth!”
To read the complete press release issued today by Profound Medical, click http://www.profoundmedical.com/May19%202010%20PR.html